This case highlights the diagnostic and management challenges of refractory multisystem sarcoidosis progressing over a two-year period despite advanced biologic therapy.
🎯 Background & Rationale
Persistent air leaks (PAL) and bronchopleural fistulas (BPF)—specifically high-grade leaks like Cerfolio Grade 4—are formidable complications following necrotizing pneumonia or infection. In patients with severe comorbidities, malnutrition, and uncontrolled diabetes who are deemed prohibitive risks for surgery and general anesthesia, traditional management options are drastically limited. This publication evaluates the feasibility and utility of flexible bronchoscopy-guided deployment of Amplatzer vascular plugs (AVPs) as a minimally invasive, lung-sparing alternative for BPF closure under local anesthesia.
👥 Study Design & Population
This publication is a Case Series evaluating two high-risk male patients:
- Patient 1: A 61-year-old man with uncontrolled diabetes mellitus (HbA1c 13.2%), severe undernutrition (BMI < 18 kg/kg/m²), type 1 respiratory failure, and loculated pyopneumothorax secondary to right middle and lower lobe necrotizing pneumonia with a Cerfolio grade 4 BPF, failing 13 days of antibiotics and dual pigtail drainage.
- Patient 2: A 51-year-old man with uncontrolled diabetes mellitus (HbA1c 9.2%), undernutrition, and right lower lobe necrotizing pneumonia complicated by a loculated pyopneumothorax and a Cerfolio grade 4 BPF, failing 8 days of drainage.
📈 Methodology & Rigor
As a clinical case report/series, the methodological rigor relies on the systematic documentation of the diagnostic workup and procedural execution:
- Localization: Flexible bronchoscopy was successfully utilized to localize the exact site of the air leak to the right lower lobe (RLL) and its segmental/basal bronchi.
- Intervention: Deployment of self-expanding nitinol mesh devices (Type 2 Amplatzer vascular plugs: 8 mm and 12 mm for Patient 1; 12 mm for Patient 2) was performed entirely under local anesthesia.
- Follow-up: Rigorous longitudinal clinical and radiological follow-up was executed, including eventual device removal at 2 to 3 months and long-term evaluation at 6 months for recurrence.
🔬 Key Findings [or Planned Endpoints]
- Procedural Success: Both procedures achieved immediate, complete resolution of the persistent air leak and prompt full lung re-expansion following AVP deployment.
- Device Management: AVPs were successfully removed at 2 to 3 months post-deployment.
- Long-term Outcomes: At 6 months of follow-up, both patients maintained sustained lung expansion without pneumothorax recurrence, and neither developed new pulmonary infections prior to or following plug removal.
⚖️ Critical Appraisal
- Strengths: Demonstrates a clever, off-label application of vascular devices for airway closure in prohibitive surgical candidates. The technical advantage of AVPs—namely that they are retrievable and allow for controlled deployment—is a major benefit over traditional non-retrievable spigots or tissue glues.
- Limitations: Being a small two-patient case series, the findings lack statistical power and broad generalizability. The success of this technique heavily depends on precise anatomical sizing, operator expertise in flexible bronchoscopy, and favorable bronchial anatomy. Furthermore, the long-term patency of the affected bronchi and functional recovery of the lung parenchyma post-removal require validation in larger cohorts.
💡 The Clinical Bottom Line
For the interventional pulmonology suite, Amplatzer vascular plugs offer a viable, lung-sparing, and retrievable bronchoscopic solution for managing high-grade bronchopleural fistulas in frail, surgically unfit patients under local anesthesia. Clinicians should keep AVPs in their procedural armamentarium as an advanced endobronchial closure tool when conventional conservative measures fail.
Abstract
Keep reading
N opens the next oneClinicians should note that the presence of targetable mutations in non-small cell lung cancer with malignant pleural disease is not associated with improved survival, based on the findings from this study.
Shape-sensing robotic-assisted bronchoscopy achieved a strict diagnostic yield of 70.2% with a low pneumothorax rate of 3.3%, demonstrating that earlier tissue diagnosis of very small pulmonary nodules is feasible and safe for clinical practice.
CT-guided fiducial placement remains a relevant technique for pre-procedural localization of peripheral lung lesions.
This study introduces ultrasound-guided trans-cannula cryobiopsy of supraclavicular lymph nodes as a novel superficial lymph node approach for tissue acquisition in 10 consecutive patients, though specific numeric success or safety results were not provided in the abstract.
Active infection is not an absolute contraindication to endobronchial valve placement, but positive pressure ventilation significantly increases clinical failure odds with an aOR of 3.00 at P < 0.001.